Exome sequencing of osteosarcoma reveals mutation signatures reminiscent of BRCA deficiency

Cited by (347)

Items 201–300 of 347

1. Potential clinical treatment prospects behind the molecular mechanism of alternative lengthening of telomeres (ALT)
   Haolu Sun, Guijuan Chen, Baochang Guo, Shushu Lv, Guojun Yuan · 2023 · Journal of Cancer
2. Chromoanagenesis in Osteosarcoma
   Guozhuang Li, Nan Wu, Jen Ghabrial, Victoria Stinnett, Melanie Klausner, Laura A. Morsberger, Patty Long, Ezra G. Baraban, John M. Gross, Ying S. Zou · 2025 · Biomolecules
3. Aberrant EZHIP expression drives tumorigenesis in osteosarcoma
   Wajih Jawhar, Geoffroy Danieau, Alva Annett, Takeaki Ishii, Andrea Bajic, Ana Castillo-Orozco, Brian Krug, Yara Faucher-Jabado, Justin Seyedmoomenkashi, Muhammad Saquib et al. · 2025 · Nature Communications
4. Radioresistance in rhabdomyosarcomas: Much more than a question of dose
   Simona Camero, Matteo Cassandri, Silvia Pomella, Luisa Milazzo, Francesca Vulcano, Antonella Porrazzo, Giovanni Barillari, Cinzia Marchese, Silvia Codenotti, Miriam Tomaciello et al. · 2022 · Frontiers in Oncology
5. Evaluation of patritumab with or without erlotinib in combination with standard cytotoxic agents against pediatric sarcoma xenograft models
   Abhik M. Bandyopadhyay, Edward Favours, Doris A. Phelps, Vanessa Del Pozo, Samson Ghilu, Dias Kurmashev, Joel Edmund Michalek, Aron Trevino, Denis C. Guttridge, Cheryl A. London et al. · 2017 · Pediatric Blood & Cancer
6. Longitudinal characterization of primary osteosarcoma and derived subcutaneous and orthotopic relapsed patient-derived xenograft models
   Maria Eugénia Marques Da Costa, Robin Droit, Pierre Khneisser, Anne Gomez‐Brouchet, Tiphaine Adam de Beaumais, Marie Nolla, Nicolas Signolles, Jacob Torrejon-Diaz, Bérangère Lombard, Damarys Loew et al. · 2023 · Frontiers in Oncology
7. Identification of New Potential Prognostic and Predictive Markers in High-Grade Osteosarcoma Using Whole Exome Sequencing
   Raffaele Gaeta, Mariangela Morelli, Francesca Lessi, Chiara Maria Mazzanti, Michele Menicagli, Rodolfo Capanna, Lorenzo Andreani, Luca Coccoli, Paolo Aretini, Alessandro Franchi · 2023 · International Journal of Molecular Sciences
8. Radiosensitization of Osteosarcoma Cells Using the PARP Inhibitor Olaparib Combined with X-rays or Carbon Ions
   Meng Dong, Hongtao Luo, Ruifeng Liu, Jinhua Zhang, Zhen Yang, Dandan Wang, Yuhang Wang, Junru Chen, Yuhong Ou, Qiuning Zhang et al. · 2023 · Journal of Cancer
9. The long non-coding RNA PARTICLE is associated with WWOX and the absence of FRA16D breakage in osteosarcoma patients
   Valerie B. O’Leary, Doris Maugg, Jan Smida, Daniel Baumhoer, Michaela Nathrath, Saak Victor Ovsepian, Michael John Atkinson · 2017 · Oncotarget
10. Cell Differentiation Trajectory-Associated Molecular Classification of Osteosarcoma
    Ankai Xu, Chao Qian, Jinti Lin, Wei Yu, Jiakang Jin, Bing Liu, Huimin Tao · 2021 · Genes
11. IncRNA MALAT1 Regulates the Proliferation, Apoptosis, Migration, and Invasion of Osteosarcoma Cells by Targeting miR-873-5p/ROCK1
    Fan Yang, Mao Wang, Junlong Shi, Gang Xu · 2022 · Critical Reviews in Eukaryotic Gene Expression
12. Transformed Canine and Murine Mesenchymal Stem Cells as a Model for Sarcoma with Complex Genomics
    Natasja Franceschini, Bas Verbruggen, Marianna A. Tryfonidou, Alwine B. Kruisselbrink, Hans J. Baelde, Karin E. de Visser, Károly Szuhai, Anne‐Marie Cleton-Jansen, Judith V.M.G. Bovée · 2021 · Cancers
13. The correlation between clinical outcomes and genomic analysis with high risk factors for the progression of osteosarcoma
    Weifeng Liu, Huanqing Cheng, Zhen Huang, Yaping Li, Yanrui Zhang, Yongkun Yang, Tao Jin, Yang Sun, Zhiping Deng, Qing Zhang et al. · 2023 · Molecular Oncology
14. Decoding osteosarcoma from heterogeneity to precision therapy
    Yu Xu, Yanfu Bai, Fan Yang, Binbin Yang, Zhisheng Huang, Lingling Su, Kuntao Peng · 2025 · Discover Oncology
15. CDK4 is co-amplified with either TP53 promoter gene fusions or MDM2 through distinct mechanisms in osteosarcoma
    Karim H. Saba, Valeria Difilippo, Emelie Styring, Jenny Nilsson, Linda Magnusson, Hilda van den Bos, René Wardenaar, Diana C.J. Spierings, Floris Foijer, Michaela Nathrath et al. · 2024 · npj Genomic Medicine
16. Poly (ADP-ribose) polymerase 1 (PARP1) inhibition promotes pulmonary metastasis of osteosarcoma by boosting ezrin phosphorylation
    Fangfei Li, Xiaoqiu Wu, Xuekun Fu, Jin Liu, Wangze Song, Gary Guishan Xiao, Aiping Lü, Ge Zhang · 2022 · International Journal of Biological Sciences
17. Subsequent primary neoplasms among bone sarcoma survivors; increased risks remain after 30 years of follow-up and in the latest treatment era, a nationwide population-based study
    Asle Charles Hesla, Andrea Discacciati, Panagiotis Tsagkozis, Karin Ekstrom Ekstroem Smedby · 2020 · British Journal of Cancer
18. Osteosarcoma
    Luke Tattersall, Zoë Davison, Alison Gartland · 2019 · Elsevier eBooks
19. Ligand-dependent hedgehog signaling maintains an undifferentiated, malignant osteosarcoma phenotype
    Vijesh Vaghjiani, Catherine R. Cochrane, W. Samantha N. Jayasekara, Wai Chin Chong, Anette Szczepny, Beena Kumar, Luciano Gastón Martelotto, Andrew McCaw, Kirstyn T. Carey, Maya Kansara et al. · 2023 · Oncogene
20. Osteosarcoma Exosome Priming of Primary Human Lung Fibroblasts Induces an Immune Modulatory and Protumorigenic Phenotype
    Eric P. Palmer, Kathryn E. Cronise, Laurel A. Haines, Sunetra Das, Anne Offermann, Carina P. Easton, Daniel P. Regan · 2025 · Cancer Research Communications
21. Pharmacologic inhibition of CSF-1R suppresses intrinsic tumor cell growth in osteosarcoma with CSF-1R overexpression
    Cheng Dai, Bin Shen, Shenyan Liu, Cong Li, Shuqun Yang, Jie Wang, Jie Zhang, Manqi Liu, Zhixuan Zhu, Wan Shi et al. · 2025 · Journal of Translational Medicine
22. The CtIP-CtBP1/2-HDAC1-AP1 transcriptional complex is required for the transrepression of DNA damage modulators in the pathogenesis of osteosarcoma
    Xun Chen, Qian Zhang, Xiaoqian Dang, Jinzhu Fan, Tao Song, Zhong Li, Ning Duan, Wentao Zhang · 2022 · Translational Oncology
23. Pathogenese und genetischer Hintergrund des Osteosarkoms
    Daniel Baumhoer · 2017 · Der Pathologe
24. IMPDH2 and HPRT expression and a prognostic significance in preoperative and postoperative patients with osteosarcoma
    Parunya Chaiyawat, Areerak Phanphaisarn, Nutnicha Sirikaew, Jeerawan Klangjorhor, Viraporn Thepbundit, Pimpisa Teeyakasem, Phichayut Phinyo, Dumnoensun Pruksakorn, Jongkolnee Settakorn · 2021 · Scientific Reports
25. Decoding the immune microenvironment in osteosarcoma: new insights into checkpoints, vaccines, and CAR-T cells
    Haitian Wang, Tongtong Zhu, Kunpeng Yang, Chenkai Xu, Zhaoyi Zhang, Guangyao Liu, Hongge Ren · 2025 · Frontiers in Oncology
26. Therapeutic Targeting of DNA Repair Pathways in Pediatric Extracranial Solid Tumors: Current State and Implications for Immunotherapy
    Sophia J. Zhao, Daniel Prior, Christine M. Heske, Juan C. Vasquez · 2024 · Cancers
27. The genetic architecture of bone metastases: unveiling the role of epigenetic and genetic modifications in drug resistance
    Ahmad Dawalibi, Mohamad Adel Bakir, Khalid Said Mohammad · 2025 · Cancer Drug Resistance
28. Allelic Expression Imbalance Analysis Identified YAP1 Amplification in p53- Dependent Osteosarcoma
    Guanglin Niu, Agnieszka Bak, Melanie Nusselt, Yue Zhang, Hubert Pausch, Tatiana Flisikowska, Angelika Schnieke, Krzysztof Flisikowski · 2021 · Cancers
29. Report from the 4th European Bone Sarcoma Networking meeting: focus on osteosarcoma
    Sandra J. Strauss, Jakob Anninga, S. Rubina Baglio, Daniel Baumhoer, Sam Behjati, Stefan Bielack, Kjetil Boye, Javier Martín‐Broto, Anne‐Marie Cleton-Jansen, Andrea Degasperi et al. · 2018 · Clinical Sarcoma Research
30. Nanodynamic therapies for osteosarcoma: Recent advances and future perspectives
    Yujia Xin, Jialing Yao, Wenyan Qiao, Wan Liu, Xiufu Hua, Xiaoyan Zheng, Junfeng Hui, Daidi Fan · 2025 · Chemical Engineering Journal
31. Genome-wide profiling of prognosis-related alternative splicing signatures in sarcoma
    Weifeng Hong, Weicong Zhang, Renguo Guan, Yuying Liang, Shixiong Hu, Yayun Ji, Mouyuan Liu, Hai Lü, Min Yu, Liheng Ma · 2019 · Annals of Translational Medicine
32. Establishment, characterization, and genetic profiling of patient-derived osteosarcoma cells from a patient with retinoblastoma
    Patcharawadee Thongkumkoon, Apiwat Sangphukieo, Siripong Tongjai, Pitiporn Noisagul, Surasak Sangkhathat, Wison Laochareonsuk, Rawikant Kamolphiwong, Piyaporn Budprom, Pimpisa Teeyakasem, Petlada Yongpitakwattana et al. · 2024 · Scientific Reports
33. Molecular targeted drugs resistance impairs double-strand break repair and sensitizes ER-positive breast cancer to PARP inhibitors
    Yuna Suzuki, Wenwen Wu, Tomohiko Ohta, Shinichi Hayashi · 2021 · Breast Cancer
34. Riesenzell-haltige Tumoren des Knochens und Differenzialdiagnosen
    Birthe Heitkötter, Wolfgang Hartmann · 2022 · Der Pathologe
35. Indoleamine 2,3-Dioxygenase: A Novel Immunotherapeutic Target for Osteosarcoma
    Asim V. Farooq, Bilal Zulfiqar, Kashif Asghar · 2023 · Journal of Cancer & Allied Specialties
36. Effects of neoadjuvant zoledronate and radiation therapy on cell survival, cell cycle distribution, and clinical status in canine osteosarcoma
    Carissa J. Norquest, Anita Rogic, Phyllis A. Gimotty, Charles A. Maitz, Hansjörg Rindt, Hayley L. Ashworth, Jeffrey N. Bryan, Lindsay L. Donnelly, Angela L. McCleary‐Wheeler, Brian K. Flesner · 2024 · Frontiers in Veterinary Science
37. LncRNAs as potential prognosis/diagnosis markers and factors driving drug resistance of osteosarcoma, a review
    Siwang Hu, Han Xue-bing, Gang Liu, Shuangshuang Wang · 2024 · Frontiers in Endocrinology
38. Bibliometric analysis and visualisation of research hotspots and frontiers on omics in osteosarcoma
    Xinyu Wang, Xin Cao, Zhongshang Dai, Zhehao Dai · 2024 · Journal of Cancer Research and Clinical Oncology
39. Molekulare Pathologie in der Diagnostik der Knochentumoren: Aktueller Stand
    Daniel Baumhoer, Sylvia Höller · 2020 · Der Pathologe
40. The origin and polarization of Macrophages and their role in the formation of the Pre-Metastatic niche in osteosarcoma
    Guisen Lai, Xinyi Zhao, Yuanquan Chen, Tianwei Xie, Zepeng Su, Jiajie Lin, Keng Chen, Keng Chen · 2025 · International Immunopharmacology
41. Identification of a p53 target, CD137L, that mediates growth suppression and immune response of osteosarcoma cells
    Yusuke Tsuda, Chizu Tanikawa, Takafumi Miyamoto, Makoto Hirata, Varalee Yodsurang, Yaozhong Zhang, Seiya Imoto, Rui Yamaguchi, Satoru Miyano, Hiroshi Takayanagi et al. · 2017 · Scientific Reports
42. Whole-Exome Analysis and Osteosarcoma: A Game Still Open
    Caterina Chiappetta, Carlo Della Rocca, Claudio Di Cristofano · 2024 · International Journal of Molecular Sciences
43. Characterization of Aberrations in DNA Damage Repair Pathways in Gastrointestinal Stromal Tumors: The Clinicopathologic Relevance of γH2AX and 53BP1 in Correlation with Heterozygous Deletions of CHEK2, BRCA2, and RB1
    Tingting Liu, Chien‐Feng Li, Kien Thiam Tan, Yi‐Hua Jan, Pei‐Hang Lee, Chih‐Hao Huang, Shih-Chen Yu, Cheng‐Feng Tsao, Jui‐Chu Wang, Hsuan‐Ying Huang · 2022 · Cancers
44. Emerging predictive biomarkers in the management of bone and soft tissue sarcomas
    Candace L. Haddox, Richard F. Riedel · 2023 · Expert Review of Anticancer Therapy
45. Genomic Landscape of Osteosarcoma of Bone in an Older-Aged Patient Population and Analysis of Possible Etiologies Based on Molecular Signature
    Hatem O. Kaseb, Chichun Tan, Jeffrey P. Townsend, José C. Costa, William Bradlyn Laskin · 2024 · Genetic Testing and Molecular Biomarkers
46. SPRR1A is a potential therapeutic target for osteosarcoma: in vitro and in vivo evaluations using generated artificial osteosarcoma cancer stem cell‑like cells
    Tomohiro Miyamoto, Naomasa Fukase, Teruya Kawamoto, Shuichi Fujiwara, Hitomi Hara, R. Sawada, Yuta Nakamatsu, Yutaka Mifune, Kenichiro Kakutani, Yuichi Y. Hoshino et al. · 2024 · Oncology Reports
47. Heterozygous retinoblastoma gene mutation compromises in vitro osteogenesis of adipose mesenchymal stem cells – a temporal gene expression study
    Ambily Vincent, Viswanathan Natarajan, Vikas Khetan, Subramanian Krishnakumar, Sowmya Parameswaran · 2020 · Experimental Cell Research
48. FAT1 and MSH2 Are Predictive Prognostic Markers for Chinese Osteosarcoma Patients Following Chemotherapeutic Treatment
    Chenliang Zhou, Yong Sun, Ziying Gong, Jieyi Li, Xiaokai Zhao, Quanjun Yang, Hongjie Yu, Jianwei Ye, Jinrong Liang, Linlan Jiang et al. · 2020 · Journal of Bone and Mineral Research
49. Identification of hub genes related to metastasis and prognosis of osteosarcoma and establishment of a prognostic model with bioinformatic methods
    Zheng Fu, Guofeng Sun, Jingtian Li, Hongjian Yu · 2024 · Medicine
50. Markers for bone sarcomas
    Gonzague Du Bouexic De Pinieux, Anne Gomez‐Brouchet, Corinne Bouvier · 2014 · Elsevier eBooks
51. Genetic profiling of synchronous pituitary corticotroph adenomas
    Dongyun Zhang, Karen Tsai, Cristian Santana, Keanu Javaherian, Matthew Lee, Marvin Bergsneider, Won Bae Kim, Marilene B. Wang, Harry V. Vinters, Weihong Yan et al. · 2025 · Pituitary
52. Screening FDA-Approved Oncology Drugs with Three-Dimensional Spheroids Identifies Romidepsin as a Therapeutic Candidate for Osteosarcoma
    Emily E. Seiden, Spencer M. Richardson, Leah A. Everitt, Gabrielle J. Knafler, Alyssa L. Walker, Venetia A. Whiteside, Divya Pillutla, Shrey Ramnath, Gavin P. Kinsella, Piper A. Wilburn et al. · 2025 · Cancer Research Communications
53. Targeting developmental vulnerabilities in childhood sarcomas
    Elise Young, Barnaby Kelly, Jason E. Cain · 2025 · Cancer and Metastasis Reviews
54. Bioinformatics analysis and validation of mesenchymal stem cells related gene MT1G in osteosarcoma
    Sikuan Zheng, Xifu Cheng, Sulun Ke, Linyi Zhang, Hui Wu, Dingwen He, Xigao Cheng · 2024 · Aging
55. A Primary Telangiectatic Mandibular Osteosarcoma With Germ‐Line Malignancy‐Associated DNA Damage Repair Gene Polymorphisms: A Case Report
    Muhammad Tahir, Eric Xueying Wei, Carlina Madelaire, Alice S. Yu, Guillermo A. Herrera, Rodney E. Shackelford · 2024 · Case Reports in Oncological Medicine
56. Leveraging homologous recombination repair deficiency in sarcoma
    Dea Slade, Joanna I. Loizou · 2023 · EMBO Molecular Medicine
57. Clinical, pathologic and molecular findings in 2 Rottweiler littermates with appendicular osteosarcoma
    Kate I. Silver, Joshua Mannheimer, Corey Saba, William P.D. Hendricks, Guannan Wang, Kenneth R. Day, Manisha Warrier, Jessica A. Beck, Christina N. Mazcko, Amy Kathleen LeBlanc · 2024 · Veterinary oncology.
58. Long non-coding RNA BCAR4 regulates osteosarcoma progression by targeting microRNA-1260a
    Yixin Pan, Tang Xiaolei, Yadong Xie, Huamin Zhang, Ziyu Huang, Changjia Huang · 2025 · Bulletin du Cancer
59. Complete remission with olaparib in BRIP1-mutated metastatic high-grade pleomorphic sarcoma: case study and literature review – an example of a genomic profiling-based tumor treatment, in a cancer type with high unmet clinical need
    Alexander D.J. Thooft, Sofie Joris, Celine Jacobs, David Creytens, Sylvie Rottey, Brigitte Maes, Philippe Georges Aftimos, Lore Lapeire · 2025 · Acta Oncologica
60. Single-Cell RNA Analysis of Murine Osteosarcoma Uncovers Skp2 Function in Metastasis, Genomic Instability, and Immune Activation and Reveals Additional Target Pathways
    Alexander Ferrena, Ranxin Zhang, Jichuan Wang, Xiang Yu Zheng, Barlas Göker, Giulia Barotti, Hasibagan Borjihan, Sung‐Suk Chae, Yungtai Lo, Hongling Zhao et al. · 2026 · Cancer Research Communications
61. Classifying Osteosarcoma Using Meta-Analysis of Gene Expression
    Olivia Alge, Jonathan Gryak, Yingqi Hua, Kayvan Najaria · 2018 · IEEE International Conference on Bioinformatics and Biomedicine (BIBM)
62. Die klonale Evolution des Osteosarkoms
    Daniel Baumhoer · 2016 · Der Pathologe
63. Genetics of Osteosarcomas
    Fazilet Yıldız Özdenoğlu · 2020 · Turkish Journal of Oncology
64. Sarcomas: Genetics, Cytogenetics, and Liquid Biopsy
    Lucas Delmonico, Mariana Chantre-Justino, Gilda Alves · 2024 · Interdisciplinary cancer research
65. IGF2R-Targeted Alpha Therapy of Osteosarcoma Enabled by Conjugated [ 225 Ac]Ac-Macropa-PEG 4 -IF3
    Syed Qaiser Shah, Ralph Santos‐Oliveira, Derya İlem‐Özdemir, Madeeha Shabnam · 2026 · Bioconjugate Chemistry
66. Targeting the transcriptional coactivator p300/CBP in cancer: Mechanistic insights and translational implications for osteosarcoma
    Tatsuya Masuda, Yasutoshi Tatsumi, Takayoshi Watanabe, Yasuhiko Kamikubo · 2026 · Pharmacological Research
67. Understanding and Overcoming Osteosarcoma Heterogeneity
    Sukjoo Cho, Katherine Shelmidine, Jason Todd Yustein · 2026 · Biomolecules
68. Inherent tissue homeostasis of the juvenile metaphysis provides a foundation for osteosarcoma development
    Masato Saito, Fumie Nakasuka, Nao Sankoda, Yihan Wang, Jumpei Taguchi, Sho Ohta, Yosuke Yamada, Manabu Ozawa, Satoko Sakurai, Atsushi Kondo et al. · 2026 · Nature Communications
69. Cancer stem cells and clonal evolution in bone sarcomas
    René Rodrı́guez, Jiřı́ Hatina, Stefano Gambera, Sofía T. Menéndez, Javier Garcı́a-Castro · 2021 · Elsevier eBooks
70. Carrier-free zinc-baicalein nanoherbs inhibit osteosarcoma by modulating autophagy and Wnt/β-catenin pathway
    Liwen Fu, Maryam Malekzadeh, Roya Salehi, Yingqi Hua, Chuanglong He · 2026 · Advanced Interventional Materials
71. Osteosarcoma as a communication-driven disease: redefining tumor–bone signaling networks as therapeutic targets
    Gabriele Ricciardi, Vincenzo Fiorentino, Pietro Tralongo, Maria Lentini, Ludovica Rita Pepe, Valeria Zuccalà, Mariagiovanna Ballato, Giuseppe Giuffrè, Antonio Ieni, Biagio Zampogna et al. · 2026 · Frontiers in Oncology
72. Sitzungsbericht der AG Knochen‑, Gelenk- und Weichgewebspathologie
    Stefanie Scheil-Bertram, Eva Wardelmann · 2020 · Der Pathologe
73. Novel Aspects of Genetics, Molecular Biology and Clinical Oncology of Sarcomas
    Kateřina Houfková, Jiřı́ Hatina · 2020 · Klinicka onkologie
74. Malignant Brain and Spinal Tumors Originating from Bone or Cartilage
    Zachary Charles Gersey, Georgios Andrea Zenonos, Paul A. Gardner · 2023 · Advances in experimental medicine and biology
75. DNA Mutational and Copy Number Variation Profiling of Primary Craniofacial Osteosarcomas by Next-Generation Sequencing
    Gord Guo Zhu, Chuanyong Lu, Ivana Petrović, Khédoudja Nafa, Wen Chen, Aijazuddin Syed, Satshil Rana, Michael J. Klein, Sinchun Huang, Lu Wang et al. · 2024 · Head and Neck Pathology
76. Identifying KDM5B as the synthetic lethal target of KMT2D-mutated osteosarcoma
    Liyu Yang, Jing Zhang, Yiting Jiang, Jiayu Zhang, Zhonghua Wang, Lihui Wang, Xinyu Fan, Gen Ba · 2025 · Chemico-Biological Interactions
77. Gibt es eine Magic Bullet für Sarkome?
    Susanne Scheipl, Bernadette Liegl‐Atzwanger, Joanna Szkandera, Beate Rinner, Christian Viertler, Joerg Friesenbichler, Marko Bergovec, Andreas Leithner · 2019 · Der Orthopäde
78. Osteoidbildende Knochentumoren
    Albert Roessner, Victor Schoeder, Maria Anna Smolle, Johannes Haybäck · 2020 · Der Pathologe
79. DNA Repair Defects in Sarcomas
    Niknam Riyahi, Mohammad Reza Saadatzadeh, Khadijeh Bijangi‐Vishehsaraei, Farinaz Barghi, Pankita H. Pandya, Karen E. Pollok · 2020 · IntechOpen eBooks
80. High‐grade uterine sarcoma with osteosarcomatous differentiation arising from a MED12‐mutated leiomyoma, a case report
    Minh‐Khang Le, Makiko Omori, Naoki Oishi, Megumi Oi, Hiroko Fukasawa, Shuji Hirata, Tetsuo Kondo · 2021 · Pathology International
81. Markers for bone sarcomas
    Matthias Tallegas, Anne Gomez‐Brouchet, Mélanie Legrand, Corinne Bouvier, Gonzague Du Bouexic De Pinieux · 2021 · Elsevier eBooks
82. DNA damage in 3D constricted migration or after lamin-A depletion in 2D: shared mechanisms of repair factor mis-localization under nuclear stress
    Yuntao Xia, Jerome Irianto, Charlotte R. Pfeifer, Jiazheng Ji, Irena Lambrova Ivanovska, Manu Tewari, Rachel R. Bennett, Shane M. Harding, Andrea J. Liu, Roger A. Greenberg et al. · 2016 · bioRxiv (Cold Spring Harbor Laboratory)
83. Satellite DNA fragility accompanies complex genome rearrangements and ecDNA oncogene amplification in canine osteosarcomas
    Feyza Yilmaz, Wonyoung Kong, Sabriya A. Syed, Francis H. O’Neill, Jody T Lombardi, Patrick Kwok Shing Ng, Ching C. Lau, Charles Lee · 2025 · bioRxiv (Cold Spring Harbor Laboratory)
84. Gene and proteomic profiling of osteosarcoma
    Ana Patiño‐García, Fernando Lecanda · 2014 · Elsevier eBooks
85. Sitzungsbericht der AG Knochen-, Gelenk- und Weichgewebspathologie
    Stefanie Scheil-Bertram, Veit Krenn, Kathrin Hauptmann · 2015 · Der Pathologe
86. Sitzungsbericht der AG Knochen-, Gelenk- und Weichgewebspathologie
    Stefanie Scheil-Bertram, Veit Krenn · 2016 · Der Pathologe
87. Soft Tissue and Bone Neoplasms
    Peter Pytel, Nicole A. Cipriani · 2018 · Molecular pathology library
88. Advances in Sarcoma Genomics and Therapeutic Management
    Nagavalli Somasundaram, Sock Hoai Chan, Richard Hong Hui Quek, Joanne Yuen Yie Ngeow · 2018 · Elsevier eBooks
89. Caracterização de alterações genômicas caóticas em osteossarcoma
    Alexandra Galvão Gomes · 2019 · Digital Library of Theses and Dissertations (Universidade de São Paulo)
90. Biology of Osteosarcomas
    Massimo Serra, Claudia Maria Hattinger · 2019 · Springer eBooks
91. Investigation of Intratumoral Heterogeneity in Sarcoma Progression and Metastasis: From Tumor Propagating Cell Dynamics to Clonal Evolution
    Yuning J. Tang · 2019 · TSpace (University of Toronto)
92. RECQL4; Linking DNA Replication and Bone Tumourigenesis
    Author, Unknown · 2019 · Lincoln Repository (University of Lincoln)
93. Syndromic osteosarcoma, does it carry a poor prognosis? King Hussein Cancer Center experience. A case series report with literature review
    Abdulqader Al‐Hebshi, Taleb Ismael · 2020 · World Journal of Advanced Research and Reviews
94. Investigation of the Effects of Alterations in the Glutamate Receptor, GRIK2 on Osteosarcoma Tumourigenesis
    Justin G. Mayers · 2019 · TSpace (University of Toronto)
95. MODERN IDEAS ABOUT CLONAL EVOLUTION OF SARCOMAS
    N.A. Avdonkina, Anna Borisovna Danilova, Т. Л. Нехаева, Ирина Александровна Балдуева · 2019 · Voprosy Onkologii
96. Therapeutic vulnerability to PARP1/2 inhibition in RB1 -mutant osteosarcoma
    Georgia Zoumpoulidou, Carlos Alvarez-Mendoza, Caterina Mancusi, Ritika-Mahmuda Ahmed, Milly Denman, Christopher D. Steele, Jiten Manji, Nischalan Pillay, Sandra J. Strauss, Sibylle Mittnacht · 2020 · bioRxiv (Cold Spring Harbor Laboratory)
97. Generating Isogenic Models of Li-Fraumeni Syndrome and Restoring p53 using CRISPR
    James Tran · 2020 · TSpace (University of Toronto)
98. The use of massively parallel sequencing to study the virome, epigenome and genome of canine and feline cancers
    Shirley Chu · 2019 · MOspace Institutional Repository (University of Missouri)
99. Genetic aspects of primary bone tumors
    Camila Morais Melo, Jeremy Andrew Squire · 2021 · Elsevier eBooks
100. Regulated cell death and drug resistance in malignant bone tumors
     Günther H.S. Richter, Andrej Lissat, Udo Kontny · 2021 · Elsevier eBooks